Vineet Laboratories (NSE:VINEETLAB) Other Current Liabilities: ₹0.0 Mil (As of Dec. 2025)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
41 GF Score
Price ₹32.21
GF Value ₹15.28
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories Other Current Liabilities?

Vineet Laboratories NSE:VINEETLAB -1.38% 41 Other Current Liabilities is ₹0.0 Mil as of Dec. 2025. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 41/100 and a GF Value™ of ₹15.28 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Vineet Laboratories's other current liabilities for the quarter that ended in Dec. 2025 was ₹0.0 Mil.

Vineet Laboratories's quarterly other current liabilities increased from Jun. 2025 (₹28.7 Mil) to Sep. 2025 (₹31.5 Mil) but then declined from Sep. 2025 (₹31.5 Mil) to Dec. 2025 (₹0.0 Mil).

Vineet Laboratories's annual other current liabilities declined from Mar. 2023 (₹107.1 Mil) to Mar. 2024 (₹7.8 Mil) but then increased from Mar. 2024 (₹7.8 Mil) to Mar. 2025 (₹14.5 Mil).

Vineet Laboratories Other Current Liabilities Related Terms

Vineet Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories Other Current Liabilities Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 13.91 0.00 107.13 7.82 14.48

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.38 14.48 28.72 31.46 0.00
NSE:VINEETLAB
41GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹0.0 Mil mean?
Vineet Laboratories (NSE:VINEETLAB) has a Other Current Liabilities of ₹0.0 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Vineet Laboratories.
Is Vineet Laboratories' Other Current Liabilities too high?
Vineet Laboratories' current Other Current Liabilities is ₹0.0 Mil. Overall, Vineet Laboratories has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Other Current Liabilities compare to DOW?
Vineet Laboratories' Other Current Liabilities of ₹0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Chemicals company?
A good Other Current Liabilities depends on the Chemicals industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Vineet Laboratories. Vineet Laboratories's current Other Current Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.28, compared to a current price of ₹32.21 — trading 110.8% above its estimated fair value. The current Other Current Liabilities is ₹0.0 Mil. Vineet Laboratories' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Other Current Liabilities is ₹0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹32.21 is trading 110.8% above its estimated GF Value™ of ₹15.28. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Other Current Liabilities: ₹0.0 Mil
  • GF Value™: ₹15.28 vs. price of ₹32.21 (110.8% above fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
41GF Score

Get the complete analysis for NSE:VINEETLAB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.21
Price
₹15.28
GF Value